Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Venture Capital Resilient For MedTech Even As Public Markets Wilt – Report

This article was originally published in The Gray Sheet

Executive Summary

The U.S. medical technology industry's access to private venture capital remained largely intact in the first half of 2008, despite a global credit crunch that has depressed public equity financing in the sector, according to a 1report by consulting firm Ernst & Young
Advertisement

Related Content

Venture Capital For MedTech “Somewhat Resilient,” With 18% Drop In ’08
Venture Capital For MedTech “Somewhat Resilient,” With 18% Drop In ’08
CSI Takes Reverse Merger Route To Public Market As IPO Options Fade
CSI Takes Reverse Merger Route To Public Market As IPO Options Fade
Economy May Push Med-Tech Innovation From Start-Ups To Larger Firms
Economy May Push Med-Tech Innovation From Start-Ups To Larger Firms
Advertisement
UsernamePublicRestriction

Register

MT026630

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel